Catalog |
name |
Description |
price |
R-C-3091 |
TAK-593 CAS:1005780-62-0 |
TAK-593 is an oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity.Only for scientific research, not for human body. |
price> |
R-C-3092 |
SU5402 CAS:215543-92-3 |
SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.Only for scientific research, not for human body. |
price> |
R-C-3093 |
SAR131675 CAS:1433953-83-3 |
SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.Only for scientific research, not for human body. |
price> |
R-C-3094 |
SU 5416 (Semaxinib) CAS: 204005-46-9 |
SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.Only for scientific research, not for human body. |
price> |
R-C-3095 |
CP-547632 CAS:252003-65-9 |
CP-547632 is a novel, potent vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor.Only for scientific research, not for human body. |
price> |
R-C-3096 |
CP-673451 CAS:343787-29-1 |
CP-673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM in cell-free assays, exhibits >450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.Only for scientific research, not for human body. |
price> |